- US-listed companies
- AGIOS PHARMACEUTICALS, INC.
- Balance sheet
AGIOS PHARMACEUTICALS, INC.【AGIO】Balance sheet
Market cap
$1.7B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 72 | 14 | 72 | 161 | 103 | 71 | 81 | 127 | 203 | 139 | 88 | 76 |
| Marketable securities, current | 95 | 328 | 245 | 761 | 321 | 1,030 | 484 | 445 | 817 | 644 | 689 | 817 |
| Total cash & short-term investments | 167 | 342 | 317 | 922 | 424 | 1,100 | 565 | 573 | 1,020 | 783 | 777 | 894 |
| Inventories | - | - | - | - | - | 1 | 7 | 15 | - | 8 | 19 | 28 |
| Total current assets | 170 | 360 | 337 | 560 | 445 | 614 | 612 | 637 | 1,064 | 833 | 834 | 966 |
| Property, plant and equipment, net | 4 | 6 | 23 | 25 | 24 | 24 | 31 | 32 | 29 | 23 | 15 | 12 |
| Marketable securities, non-current | 27 | 125 | 59 | 32 | 144 | 220 | 153 | 98 | 266 | 314 | 29 | 638 |
| Total non-current assets | 31 | 132 | 83 | 59 | 169 | 245 | 279 | 216 | 374 | 406 | 103 | 698 |
| Total assets | 201 | 492 | 420 | 619 | 614 | 858 | 891 | 853 | 1,438 | 1,239 | 937 | 1,663 |
| Accounts payable | 4 | 11 | 15 | 17 | 23 | 18 | 22 | 27 | 17 | 19 | 10 | 17 |
| Total current liabilities | 37 | 61 | 53 | 88 | 95 | 94 | 93 | 94 | 60 | 63 | 68 | 81 |
| Total non-current liabilities | - | - | - | - | 144 | 77 | 157 | 359 | 86 | 75 | 58 | 41 |
| Total liabilities | - | - | - | - | 239 | 171 | 250 | 453 | 146 | 138 | 126 | 122 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Retained earnings | -113 | -167 | -285 | -483 | -798 | -1,105 | -1,516 | -1,843 | -239 | -471 | -823 | -149 |
| Stockholders' equity | 131 | 424 | 345 | 359 | 376 | 688 | 641 | 400 | 1,292 | 1,101 | 811 | 1,541 |